These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 34724875)
1. Requirement for containing etoposide in the initial treatment of lymphoma associated hemophagocytic lymphohistiocytosis. Song Y; Wang J; Wang Y; Wu L; Wang Z Cancer Biol Ther; 2021 Dec; 22(10-12):598-606. PubMed ID: 34724875 [TBL] [Abstract][Full Text] [Related]
2. Autologous Hematopoietic Stem Cell Transplantation for Patients with Lymphoma-Associated Hemophagocytic lymphohistiocytosis. Song Y; Yin Q; Wang J; Wang Z Cell Transplant; 2021; 30():9636897211057077. PubMed ID: 34743574 [TBL] [Abstract][Full Text] [Related]
3. Requirement for etoposide in the initial treatment of Epstein-Barr virus-associated haemophagocytic lymphohistiocytosis. Song Y; Wang Y; Wang Z Br J Haematol; 2019 Sep; 186(5):717-723. PubMed ID: 31115044 [TBL] [Abstract][Full Text] [Related]
4. [Treatment outcomes and prognostic analysis of 61 Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis]. Zeng X; Wei N; Wang Y; Wang J; Zhang J; Wu L; Huang W; Gao Z; Pei R; Chen J; Jin Z; Wang Z Zhonghua Xue Ye Xue Za Zhi; 2015 Jun; 36(6):507-10. PubMed ID: 26134018 [TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr Virus-Positive Lymphoma-Associated Hemophagocytic Syndrome: A Retrospective, Single-Center Study of 51 Patients. Zhao A; Yang J; Li M; Li L; Gan X; Wang J; Li H; Shen K; Yang Y; Niu T Front Immunol; 2022; 13():882589. PubMed ID: 35479073 [TBL] [Abstract][Full Text] [Related]
6. The emerging role of anti-PD-1 antibody-based regimens in the treatment of extranodal NK/T-cell lymphoma-associated hemophagocytic lymphohistiocytosis. He Y; Gao Y; Ping L; He H; Huang C; Bai B; Wang X; Li Z; Cai Q; Huang Y; Pan X; Zeng W; Liu Y; Huang H J Cancer Res Clin Oncol; 2023 May; 149(5):2017-2027. PubMed ID: 35809114 [TBL] [Abstract][Full Text] [Related]
7. Multivariate analysis of prognosis for patients with natural killer/T cell lymphoma-associated hemophagocytic lymphohistiocytosis. Jin Z; Wang Y; Wang J; Wu L; Pei R; Lai W; Wang Z Hematology; 2018 May; 23(4):228-234. PubMed ID: 28982299 [TBL] [Abstract][Full Text] [Related]
8. Malignancy-associated hemophagocytic lymphohistiocytosis in children: a 10-year experience of a single pediatric hematology center. Huang Z; Jia Y; Zuo Y; Wu J; Lu A; Zhang L Hematology; 2020 Dec; 25(1):389-399. PubMed ID: 33161882 [No Abstract] [Full Text] [Related]
9. [Effect of Plasma Epstein-Barr Virus Nucleic Acid Loads on the Clinical Features and Prognosis in Adult Secondary Hemophagocytic Lymphohistiocytosis]. Duan LM; Yin GL; Tian T; Wang JJ; Gao X; Cheng WY; Fang ZW; Qiu HX; Xu J Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Aug; 32(4):1238-1247. PubMed ID: 39192426 [TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in adults and adolescents-a life-threatening disease: analysis of 133 cases from a single center. Lai W; Wang Y; Wang J; Wu L; Jin Z; Wang Z Hematology; 2018 Dec; 23(10):810-816. PubMed ID: 29957156 [TBL] [Abstract][Full Text] [Related]
11. HLA-mismatched GPBSC infusion therapy in refractory Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis: an observational study from a single center. Song Y; Wang J; Wang Y; Wang Z Stem Cell Res Ther; 2020 Jul; 11(1):265. PubMed ID: 32611452 [TBL] [Abstract][Full Text] [Related]
12. Epstein Virus Barr-Positive Diffuse Large B-Cell Lymphoma Associated with Hemophagocytic Lymphohistiocytosis. Ricard JA; Charles R; Tommee CG; Yohe S; Bell WR; Flanagan ME J Neuropathol Exp Neurol; 2020 Aug; 79(8):915-920. PubMed ID: 32647871 [TBL] [Abstract][Full Text] [Related]
13. Etoposide Therapy of Cytokine Storm Syndromes. Henter JI; von Bahr Greenwood T Adv Exp Med Biol; 2024; 1448():525-551. PubMed ID: 39117837 [TBL] [Abstract][Full Text] [Related]
14. Lymphoma-based therapy for refractory or relapsed Epstein-Barr virus-related hemophagocytic lymphohistiocytosis in children. Cheng CN; Chu WY; Chang KC; Chen JS J Formos Med Assoc; 2022 Nov; 121(11):2351-2355. PubMed ID: 35123848 [TBL] [Abstract][Full Text] [Related]
15. Hodgkin lymphoma-associated hemophagocytic lymphohistiocytosis-a dangerous disease. Jin Z; Wang Y; Wei N; Wang Z Ann Hematol; 2020 Jul; 99(7):1575-1581. PubMed ID: 32500223 [TBL] [Abstract][Full Text] [Related]
16. Ruxolitinib combined with doxorubicin, etoposide, and dexamethasone for the treatment of the lymphoma-associated hemophagocytic syndrome. Zhou L; Liu Y; Wen Z; Yang S; Li M; Zhu Q; Qiu S; Gao Y; Wang H; Yuan Y; Zhang H; Chen C; Zeng W; Guan Z; Pan X J Cancer Res Clin Oncol; 2020 Nov; 146(11):3063-3074. PubMed ID: 32617699 [TBL] [Abstract][Full Text] [Related]
17. T Cell-Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis (HLH) Occurs in Non-Asians and Is Associated with a T Cell Activation State that Is Comparable to Primary HLH. Shamriz O; Kumar D; Shim J; Briones M; Quarmyne MO; Chonat S; Lucas L; Edington H; White MH; Mahajan A; Park S; Chandrakasan S J Clin Immunol; 2021 Oct; 41(7):1582-1596. PubMed ID: 34173902 [TBL] [Abstract][Full Text] [Related]
18. Elevated serum adenosine deaminase levels in secondary hemophagocytic lymphohistiocytosis. Chen W; Zhang S; Zhang W; Yang X; Xu J; Qiu H; Zhang X; Li J Int J Lab Hematol; 2015 Aug; 37(4):544-50. PubMed ID: 25764155 [TBL] [Abstract][Full Text] [Related]
19. Treatment of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis (EBV-HLH) in young adults: a report from the HLH study center. Imashuku S; Kuriyama K; Sakai R; Nakao Y; Masuda S; Yasuda N; Kawano F; Yakushijin K; Miyagawa A; Nakao T; Teramura T; Tabata Y; Morimoto A; Hibi S Med Pediatr Oncol; 2003 Aug; 41(2):103-9. PubMed ID: 12825212 [TBL] [Abstract][Full Text] [Related]